Tuesday, July 27, 2010

AMAZING Deal for ANYONE!!!

We want to do our part to help raise money for Susan G. Komen for the Cure, so from now until Thursday, August 5 we will be collecting $25 donations in exchange for an adjustment. New to chiropractic care? This is a fantastic opportunity to find out what it's all about and see for yourself the benefits adjustments can have on your overall health and wellness. Call today for an appointment - 312.850.2225

Does your baby suffer from colic?

Bring your baby to our office! Babies under chiropractic care are 2 times less likely to have colic. At our office, conveniently located in Chicago's West Loop neighborhood, colic is gone after just a few gentle adjustments. Call today to schedule your child's exam. 312-850-2225

For more information, please go to:
http://www.ncbi.nlm.nih.gov/pubmed/19836599

Tuesday, July 13, 2010

Drug of the Month: YAZ

YAZ is this month's Chiropractic Leadership Alliance drug of the month. Check out these highlights from their article.

"YAZ® (drospirenone and ethinyl estradiol) Tablets:

YAZ is indicated for the prevention of pregnancy in women who elect to use an oral contraceptive. YAZ is also indicated for the treatment of symptoms of premenstrual dysphoric disorder (PMDD) in women who choose to use an oral contraceptive as their method of contraception. The effectiveness of YAZ for PMDD when used for more than three menstrual cycles has not been evaluated.

YAZ is indicated for the treatment of moderate acne vulgaris in women at least 14 years of age, who have no known contraindications to oral contraceptive therapy and have achieved menarche. YAZ should be used for the treatment of acne only if the patient desires an oral contraceptive for birth control. YAZ has not been evaluated for the treatment of premenstrual syndrome (PMS).

YAZ contains 3 mg of the progestin drospirenone that has antimineralocorticoid activity, including the potential for hyperkalemia in high-risk patients, comparable to a 25 mg dose of spironolactone. YAZ should not be used in patients with conditions that predispose to hyperkalemia (i.e. renal insufficiency, hepatic dysfunction and adrenal insufficiency). Women receiving daily, long-term treatment for chronic conditions or diseases with medications that may increase serum potassium should have their serum potassium level checked during the first treatment cycle. Medications that may increase serum potassium include ACE inhibitors, angiotensin – II receptor antagonists, potassium-sparing diuretics, potassium supplementation, heparin, aldosterone antagonists, and NSAIDS.

The use of oral contraceptives is associated with increased risks of several serious conditions including venous and arterial thrombotic and thromboembolic events (such as myocardial infarction, thromboembolism, stroke), hepatic neoplasia, gallbladder disease, and hypertension. The risk of serious morbidity or mortality is very small in healthy women without underlying risk factors. The risk of morbidity and mortality increases significantly in the presence of other underlying risk factors such as hypertension, hyperlipidemias, obesity and diabetes."

Please visit http://www.subluxation.com/onpurpose/onpurpose-subscription-subscribers-only/drug-of-the-month/drug-of-the-month-july2010/ or call 312-850-2225 for more information.